Paralog Co-Targeting Identifies Selective Genetic Redundancies across Cancer Types.
Gauthier-Coles G, Sheltzer J. Paralog Co-Targeting Identifies Selective Genetic Redundancies across Cancer Types. Cancer Discovery 2024, 14: 2312-2314. PMID: 39618283, DOI: 10.1158/2159-8290.cd-24-1349.Peer-Reviewed Original Research